168
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Diagnostic Impact of Hs-CRP and IL-6 for Acute Coronary Syndrome in Patients Admitted to the ED with Chest Pain: Added Value to the HEART Score?

ORCID Icon, , ORCID Icon, &
Pages 333-342 | Received 04 Jul 2023, Accepted 18 Sep 2023, Published online: 21 Sep 2023

References

  • Ko DT, Dattani ND, Austin PC, et al. Emergency department volume and outcomes for patients after chest pain assessment. Circ Cardiovasc Qual Outcomes. 2018;11(11):e004683. doi:10.1161/circoutcomes.118.004683
  • Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971;43(1):67–82. doi:10.1161/01.cir.43.1.67
  • Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619. doi:10.1093/eurheartj/ehu278
  • Six AJ, Backus BE, Kingma A, Kaandorp SI. Consumption of diagnostic procedures and other cardiology care in chest pain patients after presentation at the emergency department. Neth Heart J. 2012;20(12):499–504. doi:10.1007/s12471-012-0322-6
  • Hoffmann U, Truong QA, Schoenfeld DA, et al. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med. 2012;367(4):299–308. doi:10.1056/NEJMoa1201161
  • Grace Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141(2):190–199. doi:10.1067/mhj.2001.112404
  • Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–842. doi:10.1001/jama.284.7.835
  • Than M, Cullen L, Reid CM, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011;377(9771):1077–1084. doi:10.1016/s0140-6736(11)60310-3
  • Than M, Flaws D, Sanders S, et al. Development and validation of the emergency department assessment of chest pain score and 2 h accelerated diagnostic protocol. Emerg Med Australas. 2014;26(1):34–44. doi:10.1111/1742-6723.12164
  • Reaney PDW, Elliott HI, Noman A, Cooper JG. Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events. Emerg Med J. 2018;35(7):420–427. doi:10.1136/emermed-2017-207172
  • Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008;16(6):191–196. doi:10.1007/bf03086144
  • Poldervaart JM, Langedijk M, Backus BE, et al. Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department. Int J Cardiol. 2017;227:656–661. doi:10.1016/j.ijcard.2016.10.080
  • Backus BE, Six AJ, Kelder JC, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013;168(3):2153–2158. doi:10.1016/j.ijcard.2013.01.255
  • Six AJ, Cullen L, Backus BE, et al. The HEART score for the assessment of patients with chest pain in the emergency department: a multinational validation study. Crit Pathw Cardiol. 2013;12(3):121–126. doi:10.1097/HPC.0b013e31828b327e
  • Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993;91(4):1351–1357. doi:10.1172/jci116336
  • Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA. 1987;84(20):7251–7255. doi:10.1073/pnas.84.20.7251
  • Cainzos-Achirica M, Miedema MD, McEvoy JW, et al. The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10 years of follow-up: the Multi-Ethnic Study of Atherosclerosis (Mesa). Int J Cardiol. 2018;264:158–164. doi:10.1016/j.ijcard.2018.02.027
  • Nakachi T, Kosuge M, Hibi K, et al. C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Circ J. 2008;72(12):1953–1959. doi:10.1253/circj.cj-08-0185
  • Mitchell AM, Garvey JL, Kline JA. Multimarker panel to rule out acute coronary syndromes in low-risk patients. Acad Emerg Med. 2006;13(7):803–806. doi:10.1197/j.aem.2006.03.553
  • Magadle R, Weiner P, Beckerman M, Berar-Yanay N. C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room. Clin Cardiol. 2002;25(10):456–460. doi:10.1002/clc.4960251004
  • Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
  • Bang C, Hansen C, Lauridsen KG, et al. Rapid use of high-sensitive cardiac troponin I for ruling-in and ruling-out of acute myocardial infarction (RACING-MI): study protocol. Open Heart. 2019;6(1):e000995. doi:10.1136/openhrt-2018-000995
  • Bang C, Lauridsen KG, Frederiksen CA, et al. Rapid rule-out of myocardial infarction after 30 minutes as an alternative to 1 hour: the RACING-MI cohort study. Ann Emerg Med. 2021;79:102–112. doi:10.1016/j.annemergmed.2021.08.024
  • Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/clep.S179083
  • Kones R. Rosuvastatin, inflammation, C-reactive protein, Jupiter, and primary prevention of cardiovascular disease--a perspective. Drug Des Devel Ther. 2010;4:383–413. doi:10.2147/DDDT.S10812
  • Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207. doi:10.1056/NEJMoa0807646
  • Knudsen LS, Christensen IJ, Lottenburger T, et al. Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis. Biomarkers. 2008;13(1):59–78. doi:10.1080/13547500701615017
  • Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–e651. doi:10.1161/cir.0000000000000617
  • Liyan C, Jie Z, Yonghua W, Xiaozhou H. Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes. J Clin Lab Anal. 2008;22(1):45–49. doi:10.1002/jcla.20223
  • Diercks DB, Kirk JD, Naser S, Turnipseed S, Amsterdam EA. Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients. Int J Emerg Med. 2011;4:37. doi:10.1186/1865-1380-4-37
  • Ritschel VN, Seljeflot I, Arnesen H, et al. IL-6 signalling in patients with acute ST-elevation myocardial infarction. Results Immunol. 2014;4:8–13. doi:10.1016/j.rinim.2013.11.002
  • Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352(1):20–28. doi:10.1056/NEJMoa042378
  • Mahler SA, Miller CD, Hollander JE, et al. Identifying patients for early discharge: performance of decision rules among patients with acute chest pain. Int J Cardiol. 2013;168(2):795–802. doi:10.1016/j.ijcard.2012.10.010
  • Oliver JJ, Streitz MJ, Hyams JM, et al. An external validation of the HEART pathway among emergency department patients with chest pain. Intern Emerg Med. 2018;13(8):1249–1255. doi:10.1007/s11739-018-1809-y
  • Klingenberg R, Aghlmandi S, Räber L, et al. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Eur Heart J Acute Cardiovasc Care. 2018;7(2):129–138. doi:10.1177/2048872616684678
  • Manenti ER, Bodanese LC, Camey SA, Polanczyk CA. Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes. Clin Cardiol. 2006;29(9):405–410. doi:10.1002/clc.4960290907
  • Sprivulis PC, Da Silva JA, Jacobs IG, Frazer AR, Jelinek GA. The association between hospital overcrowding and mortality among patients admitted via Western Australian emergency departments. Med J Aust. 2006;184(5):208–212. doi:10.5694/j.1326-5377.2006.tb00416.x
  • Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology. 1991;23(2):118–124. doi:10.3109/00313029109060809